| name | gc-overreplacement-fracture-risk |
| description | Recommends vertebral fracture assessment (baseline spinal x-ray or DXA) to identify unsuspected vertebral fractures in men over-replaced with glucocorticoids and at fracture risk. Use when evaluating a male hypopituitarism patient on glucocorticoids with fracture risk factors such as age >50, prior fracture, or low BMD. |
Assess vertebral fracture risk in glucocorticoid-over-replaced hypopituitarism males
STEP 1 — Gather Information
Collect patient sex, confirmation of hypopituitarism, current glucocorticoid regimen (type and daily dose), calculate hydrocortisone equivalent dose, and assess fracture risk factors (age, prior fragility fracture, BMD T‑score, hypogonadism, height loss, back pain).
STEP 2 — Rule In / Rule Out
Determine if the patient is a male with hypopituitarism, glucocorticoid over‑replaced (dose >20 mg hydrocortisone equivalent per day), and has ≥1 fracture risk factor. If yes, proceed to classification; if no, continue routine care and reassess annually.
STEP 3 — Classify or Stratify
Stratify as high risk when glucocorticoid dose exceeds 20 mg hydrocortisone equivalent daily and at least one major risk factor is present (age >50, prior vertebral fracture, BMD T‑score ≤‑1.0, or untreated hypogonadism). Otherwise classify as moderate/low risk.
STEP 4 — Decide
For high‑risk patients, obtain baseline vertebral fracture assessment via lateral thoracic‑lumbar spine radiography or DXA with vertebral fracture analysis (VFA). For moderate/low‑risk patients, optimize lifestyle, ensure adequate calcium/vitamin D, and repeat risk assessment every 12 months.
Clinical Guardrails / Mimics / Pitfalls
Do not rely solely on BMD T‑score; vertebral fractures can occur without osteoporosis. Avoid missing asymptomatic fractures by ordering imaging based on risk, not only back pain. Do not substitute lumbar spine DXA lacking VFA capability for vertebral fracture assessment. Do not continue glucocorticoid over‑replacement without periodic dose reassessment.
Concrete Clinical Example
A 48‑year‑old man with hypopituitarism on hydrocortisone 25 mg daily denies back pain but has low testosterone and a prior distal radius fracture. His GC dose exceeds physiologic replacement, so he is classified as high risk. A lateral spine X‑ray reveals a mild T12 vertebral compression fracture, prompting glucocorticoid dose reduction and initiation of bone‑protective therapy.
Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118
TODO: consider adding scripts/calc.py for the gc-overreplacement-fracture-risk calculator
